Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Pharmacy Technician
Pharmacy Week
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COPD
COVID-19
Dermatology
Diabetes
Epilepsy
Gastroenterology
Hematology
Hepatitis
HIV/AIDS
Huntington's Disease
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Rheumatoid Arthritis
RSV
Schizophrenia
Shingles
Transplant
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
Major Depressive Disorder
May 19, 2023
Stemming the Rising Tide of MDD
In the United States, major depressive disorder ranks second as a cause of disability; a recently approved medication provides a fast-acting treatment with minimal side effects.
August 3, 2022
Pharmacogenomic Testing Yields Positive Results for MDD Patients
May 13, 2022
The Pharmacist’s Role in Educating Patients About Depression
September 17, 2021
PMS and PMDD: Overview and Current Treatment Approaches
May 14, 2021
Depression
July 22, 2020
Analysis: Esketamine Effective for Major Depression But Cost Limits Use
May 15, 2020
Managing Treatment-Resistant Depression
February 16, 2018
Treating Comorbid Depression in CVD Patients
November 17, 2017
Major Depressive Disorder With Mixed Features: Recognition and Management
Load More
X
October 2024
In This Issue
Archives
Subscription
×
Full Image